abstract |
Abstract The current invention provides an oligonucleotide and its use for treating, ameliorating, preventing, delaying and/or treating a human cis-element repeat instability associated genetic neuromuscular or neurodegenerative disorder. Date Recue/Date Received 2020-12-18 |